Therapy of systemic fungal infections

Authors: Wu, JashinJ.1; Pang, KatieR.2; Huang, DavidB.; Tyring, StephenK.

Source: Dermatologic Therapy, Volume 17, Number 6, December 2004 , pp. 532-538(7)

Publisher: Wiley-Blackwell

Buy & download fulltext article:

OR

Price: $48.00 plus tax (Refund Policy)

Abstract:

: 

The incidence of both community-acquired and nosocomial fungal infections has significantly increased over the past several decades. The major factors for this increase are a heightened use of antibiotics, a growing population of the elderly and of immunocompromised patients as a result of HIV, cancer, and organ transplantation. In this article, we will review the indications, efficacy, and safety of the polyenes, imidazoles, triazoles, and other systemic antifungals in development that are used for systemic fungal infections.

Keywords: antifungal; imidazoles; polyenes; triazoles

Document Type: Research article

DOI: http://dx.doi.org/10.1111/j.1396-0296.2004.04057.x

Affiliations: 1: Department of Dermatology, University of California, Irvine, CA, 2: Department of Dermatology, Wayne State University School of Medicine, Detroit, MI,

Publication date: 2004-12-01

Related content

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page